Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ENPP2 | Q13822 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | NT5E | P21589 | 1/20 | 0.32 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.30 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11429000 | 0.99 | ENPP2 (0.33) | ENPP2LMNATSHRALDH1A1NT5E | |
| Hydrochloric Acid SCHEMBL8585892 | 0.99 | ENPP2 (0.33) | ENPP2LMNATSHRALDH1A1NT5E | |
| Water SCHEMBL28884512 | 0.99 | ENPP2 (0.33) | ENPP2LMNATSHRALDH1A1NT5E | |
| SCHEMBL28425056 | 0.99 | ENPP2 (0.33) | ENPP2LMNATSHRALDH1A1NT5E | |
| SCHEMBL28928239 | 0.82 | — | — | |
| SCHEMBL218703 | 0.82 | — | — | |
| SCHEMBL11570681 | 0.82 | — | — | |
| SCHEMBL23234323 | 0.81 | — | — | |
| SCHEMBL11321481 | 0.81 | — | — | |
| Hydrochloric Acid SCHEMBL498245 | 0.81 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 304 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113504190-B | Rapid detection method and reagent for trace copper in water quality | 广东环凯生物技术有限公司 | 2024-06-25 | — | — | CN | claimed |
| WO-2024095177-A1 | MANGANESE BIFUNCTIONAL CHELATING AGENT CONJUGATION PLATFORM FOR TARGETED MR IMAGING | THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO (CA) | 2024-05-10 | — | — | WO | claimed |
| US-11892401-B2 | Boronic acid appended naphthyl-pyridinium fluorescent saccharide sensors for early detection of gastrointestinal diseases | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2024-02-06 | — | — | US | claimed |
| CN-117482256-A | Dual-mode nano contrast agent and preparation method and application thereof | 浙大城市学院 | 2024-02-02 | — | — | CN | claimed |
| CN-117358309-A | Porphyrin/metal sulfide composite photocatalyst and preparation method thereof | 中国石油大学(华东) | 2024-01-09 | — | — | CN | claimed |
| US-20230310404-A1 | COMPOSITIONS AND METHODS FOR REDUCING LAMINITIS OF AN ANIMAL HOOF | EQUINE PODIATRY SOLUTIONS LLC (US) | 2023-10-05 | — | — | US | claimed |
| CN-116759670-A | Porphyrin water-based zinc ion battery electrolyte additive and application thereof | 东北师范大学 | 2023-09-15 | — | — | CN | claimed |
| US-20230115432-A1 | Methods and Apparatuses for Early Diagnosis of Lung Infection Acuity | DIAGNOSE EARLY, INC. | 2023-04-13 | — | — | US | claimed |
| EP-4127212-A1 | METHODS AND APPARATUSES FOR EARLY DIAGNOSIS OF LUNG INFECTION ACUITY | Diagnose Early, Inc. (US) | 2023-02-08 | — | — | EP | claimed |
| CN-115487873-A | Non-noble metal/porphyrin-based photocatalyst and preparation method thereof | 中国石油大学(华东) | 2022-12-20 | — | — | CN | claimed |
| US-20040202610-A1 | Method and apparatus including use of metalloporphyrins for subsequent optimization of radiosurgery and radiotherapy | ADAIR EDWIN L (US) | 2004-10-14 | — | — | US | claimed |
| US-20040116500-A1 | Methods and compositions to treat lung diseases | SAKALOSKY GEORGE P (US) | 2004-06-17 | — | — | US | claimed |
| US-6660762-B2 | Administering porphyrin compound; respiratory system disorders | SAKALOSKY GEORGE P (US) | 2003-12-09 | — | — | US | claimed |
| EP-1360221-A1 | MELT POLYCARBONATE CATALYST SYSTEMS | GENERAL ELECTRIC COMPANY (US) | 2003-11-12 | — | — | EP | claimed |
| US-20030004204-A1 | Methods and compositions to treat lung diseases | SAKALOSKY GEORGE P (US) | 2003-01-02 | — | — | US | claimed |
| WO-2002055584-A1 | MELT POLYCARBONATE CATALYST SYSTEMS | GENERAL ELECTRIC COMPANY (US) | 2002-07-18 | — | — | WO | claimed |
| US-6291631-B1 | CONTACTING DIARYLOXY COMPOUND WITH A DIHYDRIC PHENOL COMPOUND IN THE POLYMERIZATION CATALYST UNDER POLYCARBONATE MELT POLYMERIZATION CONDITIONS | GENERAL ELECTRIC COMPANY | 2001-09-18 | — | — | US | claimed |
| EP-1068272-A2 | IMPROVED METHOD OF MAKING SULFANATOPHENYL SUBSTITUTED PORPHINES | Kimberly-Clark Worldwide, Inc. (US) | 2001-01-17 | — | — | EP | claimed |
| WO-1999036476-A2 | IMPROVED METHOD OF MAKING SULFANATOPHENYL SUBSTITUTED PORPHINES | KIMBERLY-CLARK WORLWIDE, INC. (US) | 1999-07-22 | — | — | WO | claimed |
| US-5414080-A | Porphyrin-metallic complex intercalated layered double hydroxides | BOARD OF TRUSTEES OPERATING MICHIGAN STATE UNIVERSITY (US) | 1995-05-09 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11892401-B2 | Boronic acid appended naphthyl-pyridinium fluorescent saccharide sensors for early detection of gastrointestinal diseases | SI, FABP2, FABP6 | ENPP2 424/4885LMNA 2296/4885TSHR 349/4885 |
| US-20030004204-A1 | Methods and compositions to treat lung diseases | PPOX, BPGM, CLN6 | ENPP2 20/4885LMNA 429/4885TSHR 4437/4885 |
| US-20230310404-A1 | COMPOSITIONS AND METHODS FOR REDUCING LAMINITIS OF AN ANIMAL HOOF | COX15, HMOX2, HMOX1 | ENPP2 3251/4885LMNA 84/4885TSHR 3823/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.